Literature DB >> 8504974

Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to SeHCAT test.

S Eusufzai1, M Axelson, B Angelin, K Einarsson.   

Abstract

The synthesis of bile acids is regulated by a homeostatic mechanism in which bile acids returning to the liver from the intestine inhibit their own synthesis. Serum concentrations of the bile acid intermediate 7 alpha-hydroxy-4-cholesten-3-one reflect the rate of bile acid synthesis whereas bile acid malabsorption can be determined by the SeHCAT test. This study was done to evaluate the correlation between the two tests in humans. Twenty eight patients with chronic diarrhoea were included in the study. Fasting serum was collected for the determination of 7 alpha-hydroxy-4-cholesten-3-one, and on the same day the gamma emitting bile acid analogue SeHCAT was given orally and its fractional catabolic rate assessed by repeated external counting over the upper abdomen during the next seven days. There was a highly significant positive correlation between the two tests (Rs = 0.80, p < 0.001). The results show a close relation between intestinal loss and hepatic synthesis of bile acids and imply that analysis of 7 alpha-hydroxy-4-cholesten-3-one in serum should now be evaluated as a possible convenient method for assessing bile acid malabsorption in patients with diarrhoea.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504974      PMCID: PMC1374193          DOI: 10.1136/gut.34.5.698

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Hepatic handling of a synthetic gamma-labeled bile acid (75SeHCAT).

Authors:  G Galatola; R P Jazrawi; C Bridges; A E Joseph; T C Northfield
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

2.  Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B 12 absorption in ileal resection patients.

Authors:  H Fromm; P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-06       Impact factor: 22.682

3.  Functional diarrhoea: the acid test.

Authors:  K W Heaton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-04

4.  New method for the determination of bile acid turnover using 75Se-homocholic acid taurine.

Authors:  H Delhez; J W van den Berg; M van Blankenstein; J H Meerwaldt
Journal:  Eur J Nucl Med       Date:  1982

5.  Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH--a key determinant.

Authors:  B McJunkin; H Fromm; R P Sarva; P Amin
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

6.  Studies of the prevalence and significance of radiolabeled bile acid malabsorption in a group of patients with idiopathic chronic diarrhea.

Authors:  L R Schiller; R B Hogan; S G Morawski; C A Santa Ana; M J Bern; R P Norgaard; G W Bo-Linn; J S Fordtran
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

7.  Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue.

Authors:  E H Thaysen; M Orholm; T Arnfred; J Carl; P Rødbro
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

8.  Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man.

Authors:  H S Mekjian; S F Phillips; A F Hofmann
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

9.  Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT).

Authors:  M V Merrick; M A Eastwood; J R Anderson; H M Ross
Journal:  J Nucl Med       Date:  1982-02       Impact factor: 10.057

10.  Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test.

Authors:  S Eusufzai; S Ericsson; T Cederlund; K Einarsson; B Angelin
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

View more
  16 in total

1.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

2.  Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters.

Authors:  Natalia Mast; Marjan Shafaati; Wahiduz Zaman; Wenchao Zheng; Deborah Prusak; Thomas Wood; G A S Ansari; Anita Lövgren-Sandblom; Maria Olin; Ingemar Bjorkhem; Irina Pikuleva
Journal:  Biochim Biophys Acta       Date:  2010-03-16

3.  Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants.

Authors:  Jessica M Lee; Jessica R Ong; Laurent Vergnes; Thomas Q de Aguiar Vallim; Jonathan Nolan; Rita M Cantor; Julian R F Walters; Karen Reue
Journal:  J Lipid Res       Date:  2018-01-02       Impact factor: 5.922

4.  Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.

Authors:  Robert Battat; Marjolijn Duijvestein; Niels Vande Casteele; Siddharth Singh; Parambir S Dulai; Mark A Valasek; Larry Mimms; Judson McFarland; Kelly D Hester; Mark Renshaw; Anjali Jain; William J Sandborn; Brigid S Boland
Journal:  Clin Gastroenterol Hepatol       Date:  2018-11-15       Impact factor: 11.382

5.  An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea.

Authors:  W Gordon Brydon; Pearl Culbert; Kathleen Kingstone; Ann Jarvie; Marietta Iacucci; Merel Tenhage; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

Review 6.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

Review 7.  Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.

Authors:  Alan N Barkun; Jonathan Love; Michael Gould; Henryk Pluta; Hillary Steinhart
Journal:  Can J Gastroenterol       Date:  2013-11       Impact factor: 3.522

8.  Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum.

Authors:  G H Sauter; W Münzing; C von Ritter; G Paumgartner
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

9.  Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.

Authors:  M Camilleri; A Nadeau; W J Tremaine; J Lamsam; D Burton; S Odunsi; S Sweetser; R Singh
Journal:  Neurogastroenterol Motil       Date:  2009-03-13       Impact factor: 3.598

10.  Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry.

Authors:  Tadashi Yoshida; Akira Honda; Hiroshi Miyazaki; Yasushi Matsuzaki
Journal:  Anal Chem Insights       Date:  2008-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.